W
Wolfgang Koenig
Researcher at Technische Universität München
Publications - 130
Citations - 14704
Wolfgang Koenig is an academic researcher from Technische Universität München. The author has contributed to research in topics: Population & Coronary artery disease. The author has an hindex of 37, co-authored 130 publications receiving 10052 citations. Previous affiliations of Wolfgang Koenig include University of Ulm & McGill University.
Papers
More filters
Journal ArticleDOI
Clinical Features and Outcomes of Patients With Malignancy and Takotsubo Syndrome: Observations From the International Takotsubo Registry.
Victoria L. Cammann,Annahita Sarcon,Katharina J. Ding,Burkhardt Seifert,Ken Kato,Davide Di Vece,Konrad A. Szawan,Sebastiano Gili,Stjepan Jurisic,Beatrice Bacchi,Jozef Micek,Antonio H. Frangieh,Antonio H. Frangieh,L. Christian Napp,Miłosz Jaguszewski,Eduardo Bossone,Rodolfo Citro,Fabrizio D'Ascenzo,Jennifer Franke,Michel Noutsias,Maike Knorr,Susanne Heiner,Christof Burgdorf,Wolfgang Koenig,Holger Thiele,Carsten Tschöpe,Lawrence Rajan,Guido Michels,Roman Pfister,Alessandro Cuneo,Claudius Jacobshagen,Mahir Karakas,Adrian P. Banning,Florim Cuculi,Richard Kobza,Thomas Fischer,Tuija Vasankari,K.E. Juhani Airaksinen,Rafal Dworakowski,Christoph Kaiser,Stefan Osswald,Leonarda Galiuto,Wolfgang Dichtl,Clément Delmas,Olivier Lairez,John D. Horowitz,Martin Kozel,Petr Widimský,Petr Tousek,David E. Winchester,Ekaterina Gilyarova,Alexandra Shilova,Mikhail Gilyarov,Ibrahim El-Battrawy,Ibrahim Akin,Christian Ukena,Johann Bauersachs,Burkert Pieske,Gerd Hasenfuß,Wolfgang Rottbauer,Ruediger C. Braun-Dullaeus,Grzegorz Opolski,Philip MacCarthy,Stephan B. Felix,Martin Borggrefe,Carlo Di Mario,Filippo Crea,Hugo A. Katus,Heribert Schunkert,Thomas Münzel,Michael Böhm,Jeroen J. Bax,Abhiram Prasad,Jerold S. Shinbane,Thomas F. Lüscher,Thomas F. Lüscher,Frank Ruschitzka,Jelena R. Ghadri,Christian Templin +78 more
TL;DR: A substantial number of TTS patients show an association with malignancy, and therefore, appropriate screening for malignancies should be considered in these patients.
Journal ArticleDOI
Evaluating bococizumab, a monoclonal antibody to PCSK9, on lipid levels and clinical events in broad patient groups with and without prior cardiovascular events: Rationale and design of the Studies of PCSK9 Inhibition and the Reduction of vascular Events (SPIRE) Lipid Lowering and SPIRE Cardiovascular Outcomes Trials
Paul M. Ridker,Pierre Amarenco,Robert Brunell,Robert J. Glynn,J. Wouter Jukema,John J.P. Kastelein,Wolfgang Koenig,Steven E. Nissen,James H. Revkin,Raul D. Santos,Pamela F. Schwartz,Carla Yunis,Jean-Claude Tardif +12 more
TL;DR: The SPIRE trial as mentioned in this paper evaluated the efficacy and safety of bococizumab in the prevention of incident vascular events in high-risk populations with and without clinically evident cardiovascular disease.
Journal ArticleDOI
Air temperature and inflammatory and coagulation responses in men with coronary or pulmonary disease during the winter season.
Regina Hampel,Susanne Breitner,Regina Rückerl,Mark W. Frampton,Wolfgang Koenig,Richard P. Phipps,Heinz-Erich Wichmann,Annette Peters,Alexandra Schneider +8 more
TL;DR: This study suggests that temperature decrease is associated with change in several blood parameters, and the complex interplay of blood markers at low temperature may contribute to the observed association between cold and cardiovascular mortality and morbidity.
Journal ArticleDOI
Cost-Effectiveness of Low-Dose Colchicine after Myocardial Infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)
Michelle Samuel,Jean-Claude Tardif,Paul Khairy,François Roubille,David D. Waters,Jean Grégoire,Fausto J. Pinto,Aldo P. Maggioni,Rafael Diaz,Colin Berry,Wolfgang Koenig,Petr Ostadal,Jose Lopez-Sendon,Habib Gamra,Ghassan S. Kiwan,Marie-Pierre Dubé,Mylène Provencher,Andreas Orfanos,Lucie Blondeau,Simon Kouz,Philippe L. L’Allier,Reda Ibrahim,Nadia Bouabdallaoui,Dominic Mitchell,Marie-Claude Guertin,Jacques LeLorier,Jacques LeLorier +26 more
TL;DR: Cost-effectiveness analyses indicate that the addition of colchicine to standard-of-care therapy after myocardial infarction is economically dominant and therefore generates cost savings.
Journal ArticleDOI
C-reactive protein (CRP) and long-term air pollution with a focus on ultrafine particles.
Veronika Pilz,Kathrin Wolf,Susanne Breitner,Regina Rückerl,Wolfgang Koenig,Wolfgang Rathmann,Josef Cyrys,Annette Peters,Alexandra Schneider +8 more
TL;DR: This study adds to a scarce but growing body of literature showing associations between long-term exposure to ultrafine particles and hs-CRP, one of the most intensely studied blood biomarkers for cardiovascular health, a role within the complex mixture of ambient air pollution and their inflammatory potential.